Zobrazeno 1 - 10
of 693
pro vyhledávání: '"Long-acting injection"'
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
BackgroundInvestigation and analysis of the changes in healthcare resources and burden of schizophrenia in the real world before and after switching from oral antipsychotics (OAPs) to paliperidone palmitate once-monthly (PP1M) could provide evidence
Externí odkaz:
https://doaj.org/article/d5ddd091f8b84e80b84a2461619d8a72
Autor:
Wenyan Wang, Xiaofeng Wang, Ying Dong, David P. Walling, Pinglan Liu, Wanhui Liu, Yanan Shi, Kaoxiang Sun
Publikováno v:
Neurology and Therapy, Vol 13, Iss 2, Pp 355-372 (2024)
Abstract Introduction RYKINDO® (Rykindo) is a novel, long-acting injectable risperidone formulation administered biweekly (Q2W) through intramuscular gluteal injection for the treatment of schizophrenia in adult patients. This analysis was conducted
Externí odkaz:
https://doaj.org/article/eb5a4c92c10c427c9cebda73cdd8fb85
Autor:
Saheli Dey, Madhurima Khasnobis
Publikováno v:
Asian Journal of Medical Sciences, Vol 13, Iss 12, Pp 303-306 (2022)
Pamoate salt of atypical antipsychotic Olanzapine in long-acting injection depot formulation (OLAI) is often used in patients with schizophrenia having poor compliance. This depots formulation having a cluster of adverse events characterized by post-
Externí odkaz:
https://doaj.org/article/5e51f3c1569c4ee2af21bcaa0a8c2847
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-4 (2022)
Abstract Background Paliperidone is a second-generation antipsychotic agent that is effective in the treatment of schizophrenia and schizoaffective disorder as well as an adjunct to mood stabilizers and antidepressants for bipolar and depressive diso
Externí odkaz:
https://doaj.org/article/28b2840eb2d74032a5e90559df87f0fe
Publikováno v:
Pharmaceutics, Vol 16, Iss 2, p 266 (2024)
Quality by design (QbD) serves as a systematic approach to pharmaceutical development, beginning with predefined objectives and emphasizing an understanding of the product based on sound science and risk management. The purpose of this study is to ut
Externí odkaz:
https://doaj.org/article/2e2920637fd544198fb3c0cd03c92dfa
Autor:
Kai On Wong, Scott W. Klarenbach, Karen J. B. Martins, Pierre Chue, Serdar M. Dursun, Mark Snaterse, Alexis Guigue, Helen So, Huong Luu, Khanh Vu, Lawrence Richer
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Long-acting injectable (LAI) antipsychotics, along with community treatment orders (CTOs), are used to improve treatment effectiveness through adherence among individuals with schizophrenia. Understanding real-world medication adh
Externí odkaz:
https://doaj.org/article/785944d0a82a4feab0f3661a2c5a3f05
Autor:
Elif Özcan Tozoğlu, Gökhan Özpolat
Publikováno v:
Psikiyatride Güncel Yaklaşımlar, Vol 13, Iss Suppl 1, Pp 361-374 (2021)
The main aim of this study is to investigate the difference of transition from oral to long-acting antipsychotic treatments on caregiver burden of patients with schizophrenia. Other factors that may be related to the burden were also discussed. Careg
Externí odkaz:
https://doaj.org/article/8583bd9b431848078c5d3b9850a39e47
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tozoğlu, Elif Özcan, Özpolat, Gökhan
Publikováno v:
Psikiyatride Güncel Yaklaşımlar / Current Approaches in Psychiatry. 13(1):361-374
Externí odkaz:
https://www.ceeol.com/search/article-detail?id=1017743